| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | BUY | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.58▲ | 7.58▼ | 7.55▲ | N/A | N/A |
| MA10 | 7.58 | 7.55▲ | N/A | N/A | N/A |
| MA20 | 7.58▲ | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | N/A | N/A | N/A | N/A |
| RSI | 51.577▲ | N/A | N/A | N/A | N/A |
| STOCH | 47.692 | N/A | N/A | N/A | N/A |
| WILL %R | -53.846 | N/A | N/A | N/A | N/A |
| CCI | 20.468 | N/A | N/A | N/A | N/A |
|
Tuesday, January 06, 2026 08:55 AM
In 2025, the Nasdaq‑100® celebrated its 40th anniversary, cementing its role as the world’s leading large‑cap growth index. With over $500B in exchange‑traded products and availability across six ...
|
|
Monday, January 05, 2026 05:02 AM
HLP003 (previously referred to as CYB003): a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of major depressive disorder that has received Breakthrough Therapy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/01/26 | 7.42 | 7.65 | 7.34 | 7.58 | 221,641 |
| 12/01/26 | 7.52 | 7.62 | 7.1396 | 7.38 | 387,170 |
|
|
||||
|
|
||||
|
|